Nature of the Organization and Business (Details) - USD ($) |
1 Months Ended | |||
|---|---|---|---|---|
Sep. 30, 2021 |
Sep. 17, 2021 |
Mar. 31, 2022 |
Dec. 31, 2021 |
|
| Nature of the Organization and Business (Details) [Line Items] | ||||
| Offering costs | $ 3,445,200 | $ 3,445,200 | ||
| Underwriting fees | 2,137,800 | 2,137,800 | ||
| Underwriting expenses | $ 1,307,400 | $ 1,307,400 | ||
| Operating bank account | $ 50,321,206 | $ 52,966,706 | ||
| Working capital | $ 50,516,262 | |||
| IPO [Member] | ||||
| Nature of the Organization and Business (Details) [Line Items] | ||||
| Number of sold units (in Shares) | 4,800,000 | |||
| Price per unit (in Dollars per share) | $ 5 | |||
| Number of sold units, value | $ 24,000,000 | |||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Working capital. No definition available.
|
| X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Costs incurred during the period, such as those relating to general administration and policy maintenance that do not vary with and are not primarily related to the acquisition or renewal of insurance contracts. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Cash received on stock transaction after deduction of issuance costs. No definition available.
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Details
|